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ABSTRACT 
Background: Decreased grip strength (GS) is predictive of cardiovascular (CV) disease but 
whether it improves CV risk prediction has not been evaluated. We assessed the predictive 
value of low GS on incident CV events and overall mortality taking into account CV risk 
equations in a population-based study from Switzerland. 
Methods: 2707 adults (54.8% women, age range 50-75 years) were followed for a median time 
of 5.4 years. GS was assessed using a hydraulic hand dynamometer. CV absolute risk at baseline 
was assessed using recalibrated SCORE, Framingham and PROCAM risk equations. Incident CV 
events were adjudicated by an independent committee. 
Results: 160 deaths and 188 incident CV events occurred during follow-up. On bivariate 
analysis, low GS was associated with increased incident CV events: Hazard Ratio (HR) and (95% 
confidence interval) 1.76 (1.13-2.76), p<0.01 but not with overall mortality: HR=1.51 (0.94-
2.45), p=0.09. The association between low GS and incident CV events disappeared after 
adjusting for baseline CV risk: HR=1.23 (0.79-1.94), p=0.36; 1.34 (0.86-2.10), p=0.20 and 1.47 
(0.94-2.31), p=0.09 after adjusting for SCORE, Framingham and PROCAM scores, respectively. 
Conclusion: Low GS is not predictive of incident CV events when taking into account CV 
absolute risk. 
Abstract word count: 192 
Keywords: grip strength; CV events incidence; cardiovascular risk assessment; Switzerland; 
population-based study; adult. 
INTRODUCTION 
Grip strength (GS) has been shown to be inversely associated with risk of incident 
cardiovascular (CV) events (1, 2) and overall mortality (1, 3). The effect of low GS on CV events 
might be partly mediated by changes in CV risk factors (4); thus, the analysis of the effect of low 
GS on CV events and overall mortality should take into account basal CV risk. Basal CV risk can 
be estimated using equations such as SCORE (5), Framingham (6) and PROCAM (7). Although 
the associations of GS with incident CV events (1, 2) and overall mortality (1, 3, 8) have been 
assessed in several longitudinal studies, they were only partially adjusted on CV risk factors. 
Finally, whether low GS improves the predictive value of the existing CV risk equations remains 
to be assessed. 
Thus, the aim of this study was to assess the predictive value of low GS on CV events 
incidence and overall mortality, taking into account absolute CV risk at baseline as assessed by 
SCORE, Framingham or PROCAM equations, in a well-characterised population-based sample 
from the city of Lausanne, Switzerland (CoLaus study). 
MATERIALS AND METHODS 
Recruitment 
The detailed description of the recruitment of the CoLaus study has been published 
previously (9). Briefly, the CoLaus study is a population-based cohort exploring the biological, 
genetic and environment determinants of CV diseases. A non-stratified, representative sample 
of the population of Lausanne (Switzerland) was recruited between 2003 and 2006 based on 
the following inclusion criteria: a) age 35-75 years and b) willingness to participate. Participants 
aged over 50 years (3704 of the 6733 initially recruited, 55%) were invited to participate in a 
sub-study on frailty, which included GS assessment. 
Grip strength 
GS was assessed using the Baseline® Hydraulic Hand Dynamometer and positioning of 
the participants was done according to the American Society of Hand Therapists’s guidelines 
(10): subject seated, shoulders adducted and neutrally rotated, elbow flexed at 90°, forearm in 
neutral position and wrist between 0 and 30° of dorsiflexion. Three measurements were 
performed consecutively with the right hand. Coefficient of variation between measurements 
was 5.3%. The highest value (expressed in kg) was included in the analyses. Participants were 
also asked about their handedness. Grip strength was categorized as low or normal according 
to Fried criterion (11) that takes into account gender and body mass index. 
Clinical data 
Socio-demographic data such as education level, job position and social help, together 
with tobacco, leisure-time and occupational physical activity data were collected by 
questionnaire. Leisure-time physical activity was categorized as <2 or ≥2 periods of ≥20 minutes 
per week. Occupational activity was categorized as non-physical (when sitting or standing) and 
physical (carrying light or heavy load). Personal and family history of CV disease was elicited 
with a standardized interview questionnaire filled in by a trained recruiter. Participants also 
indicated if they were treated for hypertension, dyslipidemia or diabetes. 
Body weight and height were measured to the nearest 0.1 kg and 5 mm, respectively, 
using a Seca® scale and height gauge (Hamburg, Germany), with participants in light indoor 
clothes standing without shoes. Waist and hip circumferences were measured as recommended 
(12) at mid-way between the lowest rib and the iliac crest, and at the greater trochanters, 
respectively. Blood pressure (BP) was measured using an Omron® HEM-907 automated 
oscillometric sphygmomanometer (13) after at least 10 minutes’ rest in a seated position and 
the average of the last two measurements was used. Hypertension was defined as a systolic BP 
≥140 mmHg and/or a diastolic BP ≥90 mmHg and/or presence of an anti-hypertensive 
treatment. 
Biological data 
A fasting venous blood sample was drawn and measurements performed by the clinical 
laboratory of the Lausanne university hospital. CV risk factors included glucose, total and HDL-
cholesterol, triglycerides; LDL-cholesterol was calculated using the Friedewald formula if 
triglycerides were <4.6 mmol/L. Diabetes was defined by a fasting glucose ≥7.0 and/or presence 
of antidiabetic drug treatment. Dyslipidemia was defined either by the presence of a 
hypolipidemic drug or using the LDL-cholesterol thresholds according to the PROCAM CV score 
(7) adapted for Switzerland (14). 
Cardiovascular risk assessment 
CV risk was calculated using internationally used risk equations. As there is no consensus 
regarding which risk equation to use in Switzerland (15), we opted for the three most used 
equations: the European Society of Cardiology SCORE (5), Framingham-2001 (6) and PROCAM-
2007 (7). Framingham-2001 and SCORE have been recalibrated (16, 17) and validated on the 
Swiss population (17, 18). The SCORE, Framingham 2001 and PROCAM 2007 risk equations use 
age, gender, parental history, smoking, blood pressure, lipids and diabetes data to compute the 
10-year absolute risk of CV death, coronary heart disease (CHD) and CV events, respectively. 
Participants were categorized as low, medium, high or very high CV risk according to cutoffs 
shown in Supplementary Table 1. Participants with previous history of CV disease were 
considered at very high CV risk. 
Outcomes 
Outcomes of interest were CV events and overall deaths. CV events included 
cerebrovascular events (CBV) and CHD. CBV events were defined as transient ischemic attack, 
ischemic or hemorrhagic stroke, amaurosis fugax and transient global amnesia. CHD events 
were defined as myocardial infarction, stable or unstable angina, coronary revascularization or 
bypass grafting. Outcomes were first verified and medically documented by a trained 
investigator, and further validated using pre-defined criteria by an independent adjudication 
committee composed of internists, cardiologists and a neurologist. 
Exclusion criteria 
Participants were excluded if they presented a questionable GS or if no follow-up data 
were available. Questionable GS values were considered if the participant reported any 
condition precluding adequate measurement (i.e. pain, injury, recent surgery, osteoarthritis 
and rheumatoid arthritis, among others), irrespectively of the observed value. 
Statistical analysis 
Statistical analyses were conducted using Stata version 14.0 for windows (Stata Corp, 
College Station, Texas, USA). Descriptive analyses were expressed as number of participants 
(percentage) for categorical variables or as average ± standard deviation for continuous 
variables. Between-group comparisons were performed using chi-square and Student t-test for 
categorical and continuous variables, respectively. 
The effect of low GS on incident CV events and overall mortality was assessed using Cox 
proportional hazards models and results were expressed as hazard ratio (HR) and 95% 
confidence interval (95%CI). Bivariate and multivariate analyses were performed, and the 
following multivariate models were used: 1) adjusted on age and gender; ; 2) age, gender, 
education level, job position and social help; 3) age, gender, education level, job position, social 
help, waist-to-hip ratio and height; 4) adjusted on absolute CV risk according to SCORE; 5) 
adjusted on absolute CV risk according to Framingham 2001, and 6) adjusted on absolute CV 
risk according to PROCAM 2007. Adjustments on CV risk factors’ treatment were also 
performed. To take into account the decline in muscular performance occurring with age, 
sensitivity analyses were performed by further stratifying on tertiles of age. Statistical 
significance was assessed for a two-sided test with p<0.05. 
Power analysis was conducted using the power cox function of Stata. The following 
parameters were calculated: 1) power to consider the observed HR as statistically significant at 
p=0.05; 2) the minimum sample size to consider the observed HR as statistically significant at a 
power of 0.80 and p=0.05, and 3) the minimum detectable HR taking into account a sample size 
of 2707, 160 deaths and 188 incident CV events, a power of 0.80 and p=0.05. Power analyses 
were not performed if the observed HR was less than 1.  
Ethical statement 
The institutional Ethics Committee of the University of Lausanne (19) approved the 
baseline CoLaus study (protocol reference 16/03, decisions of 13th January and 10th February 
2003) and the approval was renewed for its follow-up (protocol reference 33/09, decision of 
23rd February 2009). All participants gave their signed informed consent before entering the 
study. 
RESULTS 
Characteristics of included and excluded participants 
The selection procedure is indicated in Figure 1. Of the initial 3704 participants aged 50 
and over, 2707 (73.1%) were retained for analysis. The characteristics of the included and 
excluded participants are summarized in Supplementary Table 2. Included participants were 
more likely right-handed and to perform leisure-time physical activity, more educated, had a 
higher job position and were less prone to smoke, to receive social help, to present with 
hypertension or dyslipidemia than excluded ones. No association was found in absolute CV risk 
using SCORE and Framingham risk equations, whereas excluded participants had slightly higher 
CV risk according to the PROCAM risk equation. 
Participants’ characteristics overall and according to GS category are summarized in 
Table 1. Participants with a low GS were older, less likely to have a high education level, 
working or performing leisure-time physical activity. Participants with a low GS were also more 
likely to receive social help and had a higher baseline absolute CV risk. GS values according to 
gender are represented in Supplementary Figure 1. Mean±standard deviation GS were 
26.1±5.3 kg for women and 42.7±8.4 kg for men. 
Association of grip strength with outcomes 
During a median follow-up time of 5.4 years, there were 160 deaths and 188 incident CV 
events. Survival curves for all causes and CV events according to GS category are shown in 
Supplementary Figure 2. Five-year overall survival was 96.9% (95% confidence interval: 96.1-
97.5) and 93.5% (88.9-96.3) for normal and low GS (P value: 0.09), respectively. Five-year CV 
events-free survival was 95.5% (94.6-96.3) and 89.0% (83.4-92.7) for normal and low GS (P 
value: 0.01), respectively.  
The unadjusted and multivariate-adjusted associations between low GS and overall 
mortality or incident CV events are described in Table 2. Unadjusted analyses showed that low 
GS was associated with a higher incidence of CV events, while no association was found with 
overall mortality. The association between low GS and incident CV events was no longer 
significant after multivariate adjustment (Table 2). Results did not change after adjustment on 
CV risk factors’ treatment (Supplementary Table 3) or after stratification by tertiles of age 
(Supplementary Tables 4 and 5). 
DISCUSSION 
This study assessed the impact of low GS on overall mortality and incident CV events in a 
prospective, population-based sample with a median 5.4-year follow-up time. Our results 
suggest that the association between low GS and incident CV events is no longer significant 
after adjusting for baseline absolute CV risk. Thus, GS measurement does not seem to be useful 
in assessing CV risk beyond traditional CV risk estimation equations. 
Grip strength and incident cardiovascular events 
Low GS was significantly associated with an increase in incident CV events on bivariate 
analysis, but this association disappeared after multivariate adjustment. These findings are in 
agreement with the study by Fujita et al. from Japan (20). However our results differ from those 
of the PURE study (1). It has to be mentioned that in the latter study, GS was reported as 5-kg 
decrease and not dichotomized in low and normal, and furthermore CV risk factors were self-
reported. Discrepancies could therefore possibility result from those methodological aspects. 
Other longer follow-up studies (2, 3, 21, 22) also showed an inverse association between 
different markers of GS (i.e. standard deviation, deciles or tertiles) and incident CV events, after 
adjustment on a small number of CV risk factors. Thus, several studies have shown an inverse 
association between GS and incident CV events, but the results are difficult to apply in a clinical 
setting as different metrics for GS have been used and no threshold below which the CV risk 
can be considered as increased was suggested. Similarly, although several studies (1, 22) 
adjusted the results for gender, this adjustment might not have cancelled out the considerable 
difference in GS levels between genders. In this study, we assessed whether a common 
definition of low GS was associated with incident CV events. Our results suggest that the effect 
of low GS on incident CV events is mediated by CV risk factors, as the association disappears 
after adjusting for absolute CV risk. Still, it would be of interest to replicate our study in other 
population-based samples, in order to confirm or infirm if a low GS is associated with incident 
CV events independently of the other CV risk factors. 
Grip strength and overall mortality 
Low GS was associated with overall mortality neither on bivariate, nor on multivariate 
analysis. These findings are partially in agreement with two studies (20, 22) showing similar 
results for women though not for men but it has been contradicted by other studies (1, 3, 8, 21) 
showing that different markers of GS were negatively associated with overall mortality. A 
possible explanation might be the relatively short follow-up time in our sample, or the fact that 
we adjusted for absolute CV risk while the other studies only adjusted on self-reported (1) or on 
a limited number of CV risk factors (3, 8, 21). Overall, our results suggest that low GS has no 
impact on overall mortality when absolute CV risk is taken into account.  
Study limitations 
This study has several limitations worth acknowledging. Firstly, GS was assessed on the 
right hand whereas approximately 7% of our participants were left-handed. Although the use of 
the non-dominant hand might lead to lower GS values, most studies reported no difference (23-
25), while some reported slightly higher values for the dominant compared to the non-
dominant hand (26, 27). Thus, GS measurement at the right hand irrespective of handedness 
will have a limited impact on the observed values. Secondly, the exclusion of questionable GS 
was based on self-reported information given by the participant (i.e. condition that may 
preclude adequate measurement), and did not rely on objective criteria. However, including all 
GS measurements led to similar conclusions for overall mortality and partially for incident CV 
events, for which small significant positive associations (p<0.05) were found after adjustment 
for Framingham or PROCAM risk equations (see Supplementary Table 6). Still, the p-values 
would not resist Bonferroni correction, and the PROCAM risk equation hasn’t been validated for 
the Swiss population. Thirdly, some events such as amaurosis fugax (AF) and transient global 
amnesia (TGA) might be wrongly reported as CV. Still, in this study, AF (N=1) and TGA (N=4) 
represented only 2.7% of CV events, so that the impact of a possible ascertainment bias is low. 
Further, excluding AF and TGA events led to similar conclusions (see Supplementary Table 7). 
Fourthly, our sample size and follow-up time period are relatively small for our low-risk 
population. However, on the whole sample, power calculations showed that the overall power 
to consider the bivariate and multivariate-adjusted HR as significant was higher than 70% in 
most cases (Table 3). The ongoing follow-up of the CoLaus study will enable assessing the 10-
year outcomes of the participants. Fifthly, one-fifth of the participants did not participate to 
follow-up, but this participation rate is comparable to the literature (5), and loss to follow-up 
has only limited impact on relative risks for exposure-risk associations (28). Sixthly, our data 
have been collected between 2003 and 2012, whereas some previous findings’ data were 
collected before 2000 (2, 22, 29). At this time, the incidence of fatal CV events was higher (30), 
which might have allowed to demonstrate the association between GS and incident CV events. 
Finally, only participants aged between 50 and 75 were included, so our findings cannot be 
extrapolated to other ages. 
Conclusion 
In a prospective, population-based sample aged 50 to 75 years, low GS was associated 
neither with overall mortality nor with incident CV events when adjusting for absolute CV risk. 
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Figure 1: Selection procedure. CoLaus Study, Lausanne, Switzerland, 2003-2012. 
 
 
 
GS: grip strength. Percentages were calculated using the baseline sample size as denominator. 
  
Table 1: Characteristics of participants, overall and by grip strength categories. CoLaus Study, 
Lausanne, Switzerland, 2003-2012. 
 All Normal Low P value 
N 2707 2521 186  
Right-handedness (%) 92.0 91.9 93.2 0.52 
Grip strength (kg) 33.6 ± 10.7 34.5 ± 10.5 21.7 ± 6.5 <0.01 
Age (years) 60.7 ± 6.8 60.4 ± 6.7 64.5 ± 7.0 <0.01 
Female (%) 54.8 55.0 51.6 0.37 
Smoking (%)    0.42 
Current 22.9 23.2 19.4  
Never 39.1 38.8 42.5  
Former 38.0 38.0 38.2  
Physical job (%) 15.2 15.2 14.1 0.67 
Weekly leisure-time physical activity    <0.01 
<2 periods of 20+ minutes 
    
42.2 41.4 53.2  
≥2 periods of 20+ minutes 57.8 58.6 46.8  
Living alone (%) 35.1 34.9 38.2 0.37 
Education level (%)    <0.01 
Low 58.5 57.7 69.4  
Middle 24.5 24.9 19.4  
High 17.0 17.4 11.3  
Job position (%)    <0.01 
Low 12.7 12.4 16.7  
Middle 33.8 35.1 15.1  
High 10.7 11.2 4.8  
Not working 42.9 41.3 63.4  
Receiving social help (%) 30.0 28.1 55.4 <0.01 
Risk categories (SCORE) (%)    <0.01 
Low 41.3 42.6 24.3  
Medium 
 
14.3 14.4 12.4  
High 
 
16.7 17.1 11.9  
Very high 27.7 25.9 51.4  
Risk categories (Framingham) (%)    <0.01 
Low 75.8 76.8 61.8  
Medium 
 
10.1 10.0 11.3  
High 
 
3.7 3.6 5.9  
Very high 10.4 9.6 21.0  
Risk categories (PROCAM) (%)    <0.01 
Low 55.7 56.7 43.3  
Medium 
 
20.4 20.1 23.3  
High 
 
10.5 10.7 7.8  
Very high 13.5 12.6 25.6  
Results are expressed as mean ± standard deviation or as percentage. Statistical analyses by chi-square or 
Student’s t-tests comparing normal and low grip strength categories. 
  
Table 2: Association between low grip strength, overall mortality and incident cardiovascular 
events, unadjusted and multivariate-adjusted. CoLaus Study, Lausanne, Switzerland, 2003-2012. 
 
Overall mortality Incident cardiovascular events 
 
HR [95% CI]  P value HR [95% CI] P value 
Unadjusted 1.51 0.94-2.45 0.09 1.76 1.13-2.76 0.01 
Model 1 1.15 0.71-1.88 0.57 1.22 0.78-1.93 0.39 
Model 2 1.08 0.66-1.77 0.75 1.07 0.68-1.70 0.76 
Model 3 0.98 0.59-1.63 0.95 0.96 0.60-1.55 0.87 
Model 4 1.13 0.69-1.85 0.62 1.23 0.79-1.94 0.36 
Model 5 1.40 0.86-2.27 0.17 1.34 0.86-2.10 0.20 
Model 6 1.40 0.86-2.27 0.18 1.47 0.94-2.31 0.09 
 
Results are expressed as Hazard Ratio (HR) and 95% confidence interval (CI) for low grip strength using 
normal grip strength as the reference. Statistical analyses performed by Cox proportional hazard model, 
unadjusted and adjusted for: 1) age and gender; 2) age, gender, education level, job position and social 
help; 3) age, gender, education level, job position, social help, waist-to-hip ratio and height; 4) absolute 
CV risk according to SCORE risk equation; 5) absolute CV risk according to Framingham 2001 risk 
equation, and 6) absolute CV risk according to PROCAM 2007 risk equation. 
  
Table 3: power analyses for the results indicated in table 2. CoLaus Study, Lausanne, 
Switzerland, 2003-2012. 
 
Overall mortality Incident cardiovascular events 
 
Power MSS MDHR Power MSS MDHR 
Unadjusted 0.899 5,722 1.82 0.966 2,225 1.67 
Model 1 0.719 80,981 2.15 0.756 36,694 2.08 
Model 2 0.657 308,097 2.27 0.659 397,587 2.27 
Model 4 0.689 113,599 2.21 0.756 33,857 2.08 
Model 5 0.866 9,593 1.88 0.836 13,820 1.94 
Model 6 0.866 9,593 1.88 0.896 6,630 1.83 
 
Results are expressed as power to consider the observed HR>1 as statistically significant at 
p=0.05; the minimum sample size (MSS) to consider the observed HR>1 as statistically 
significant at a power of 0.80 and p=0.05, and the minimum detectable HR (MDHR) taking into 
account a sample size of 2707, 160 deaths and 188 incident CV events, a power of 0.80 and 
p=0.05. Calculations using the power cox function of Stata. Power analyses were not performed 
for model 3 as the observed HR were less than 1. 
 
Supplementary information 
Supplementary table 1: 10-year absolute CV risk categorization for SCORE, Framingham and 
PROCAM cardiovascular risk equations. CoLaus Study, Lausanne, Switzerland, 2003-2012. 
Risk categories SCORE Framingham PROCAM 
Low (%) [0, 1.5[ [0, 5[ [0, 5[ 
Medium (%) [1.5, 2.5[ [5, 10[ [5, 10[ 
High (%) [2.5, 5.0[ [10, 20[ [10, 20[ 
Very high (%) [5.0 + [20 + [20 + 
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Supplementary table 2: Socio-demographic and clinical characteristics of included and excluded 
participants. CoLaus Study, Lausanne, Switzerland, 2003-2012. 
 Included Excluded P value 
N 2707 843  
Right-handedness (%) 92.0 89.3 0.02 
Grip strength (kg) 33.6 ± 10.7 32.7 ± 11.2 0.03 
Age (years) 60.7 ± 6.8 61.0 ± 6.9 0.30 
Female (%) 54.8 54.6 0.91 
Smoking status (%)   <0.01 
 Current 22.9 24.0  
Never 39.1 44.1  
Former 38.0 31.9  
Physical job (%) 15.2 17.9 0.06 
Weekly leisure-time physical activity    <0.01 
      <2 periods of 20+ minutes 
 
42.2 48.8  
≥2 periods of 20+ minutes 57.8 51.3  
Living alone (%) 35.1 35.9 0.69 
Education level (%)   <0.01 
Low 58.5 68.1  
Middle 24.5 18.3  
High 17.0 13.6  
Job position (%)   <0.01 
Low 12.7 19.9  
Middle 33.8 27.9  
High 10.7 6.8  
Not working 42.9 45.4  
Receive social help (%) 30.0 36.3 <0.01 
Hypertension (%) 47.9 57.4 <0.01 
Dyslipidemia (%) 38.7 45.2 <0.01 
Diabetes (%) 9.6 10.6 0.42 
Risk categories (SCORE)   0.19 
Low 41.3 37.3  
Medium  14.3 14.4  
High  16.7 17.9  
Very high 27.7 30.4  
Risk categories (Framingham)    0.27 
Low 75.8 73.4  
Medium  10.1 12.5  
High  3.7 3.6  
Very high 10.4 10.6  
Risk categories (PROCAM)    0.01 
Low 55.7 49.6  
Medium  20.4 21.8  
High  10.5 13.4  
Very high 13.5 15.2  
    
Results are expressed as mean ± standard deviation or as percentage. Statistical analyses by chi-square or Student t-test.   
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Supplementary Table 3: Association between low grip strength, overall mortality and incident 
cardiovascular events, unadjusted and adjusted for cardiovascular absolute risk and 
cardiovascular risk factors’ treatment. CoLaus Study, Lausanne, Switzerland, 2003-2012. 
 
Overall mortality Incident cardiovascular events 
 
HR [95% CI]  P value HR [95% CI] P value 
Unadjusted 1.51 0.94-2.45 0.09 1.76 1.13-2.76 0.01 
Model A 0.99 0.60-1.64 0.97 1.12 0.71-1.77 0.62 
Model B 1.13 0.68-1.87 0.65 1.21 0.76-1.91 0.42 
Model C 1.12 0.67-1.87 0.66 1.37 0.86-2.17 0.18 
 
Results are expressed as Hazard Ratio (HR) and 95% confidence interval (CI) for low grip strength using 
normal grip strength as the reference. Statistical analyses performed by Cox proportional hazard model, 
unadjusted and adjusted for treatment for hypertension, dyslipidemia and diabetes, with a further 
adjustment on: A) absolute CV risk according to SCORE risk equation; B) absolute CV risk according to 
Framingham 2001 risk equation, and C) absolute CV risk according to PROCAM 2007 risk equation. 
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Supplementary Table 4: Association between low grip strength and overall mortality, unadjusted and multivariate-adjusted, 
stratified by tertiles of age. CoLaus Study, Lausanne, Switzerland, 2003-2012. 
 
1st tertile 2nd tertile 3rd tertile 
 
HR [95% CI] P value HR [95% CI] P value HR [95% CI] P value 
Unadjusted 1.14 0.15-8.43 0.897 0.80 0.19-3.34 0.762 1.32 0.77-2.28 0.316 
Model 1 1.18 0.16-8.77 0.870 0.85 0.20-3.57 0.826 1.20 0.70-2.07 0.508 
Model 2 0.81 0.10-6.32 0.842 0.42 0.09-1.88 0.256 1.24 0.72-2.16 0.442 
Model 3 0.63 0.08-5.01 0.661 0.43 0.09-2.06 0.289 1.05 0.59-1.89 0.866 
Model 4 1.16 0.16-8.59 0.883 0.57 0.13-2.48 0.455 1.23 0.71-2.13 0.458 
Model 5 1.07 0.14-7.98 0.946 0.61 0.14-2.66 0.508 1.34 0.77-2.30 0.293 
Model 6 1.48 0.20-11.1 0.703 0.57 0.13-2.49 0.458 1.42 0.82-2.46 0.207 
 
Results are expressed as Hazard Ratio (HR) and 95% confidence interval (CI) for low grip strength using normal grip strength as the reference. 
Statistical analyses performed by Cox proportional hazard model, unadjusted and adjusted for: 1) age and gender; 2) age, gender, education 
level, job position and social help; 3) age, gender, education level, job position, social help, waist-to-hip ratio and height; 4) absolute CV risk 
according to SCORE risk equation; 5) absolute CV risk according to Framingham 2001 risk equation, and 6) absolute CV risk according to PROCAM 
2007 risk equation. 
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Supplementary Table 5: Association between low grip strength and cardiovascular event incidence, unadjusted and multivariate-
adjusted, stratified by tertiles of age. CoLaus Study, Lausanne, Switzerland, 2003-2012. 
 
 
1st tertile 2nd tertile 3rd tertile 
 
HR [95% CI] P value HR [95% CI] P value HR [95% CI] P value 
Unadjusted 1.00 0.14-7.41 0.993 1.35 0.49-3.75 0.562 1.41 0.84-2.38 0.195 
Model 1 1.09 0.15-8.03 0.934 1.49 0.54-4.15 0.444 1.21 0.71-2.04 0.483 
Model 2 0.65 0.09-5.02 0.683 0.95 0.34-2.70 0.927 1.14 0.67-1.94 0.628 
Model 3 0.51 0.06-4.02 0.523 0.95 0.33-2.77 0.924 0.99 0.57-1.73 0.971 
Model 4 1.05 0.14-7.74 0.964 1.06 0.38-2.98 0.906 1.30 0.77-2.19 0.332 
Model 5 0.94 0.13-7.02 0.950 1.15 0.41-3.23 0.795 1.21 0.72-2.04 0.473 
Model 6 1.09 0.15-8.10 0.930 1.23 0.44-3.45 0.695 1.40 0.83-2.37 0.208 
 
Results are expressed as Hazard Ratio (HR) and 95% confidence interval (CI) for low grip strength using normal grip strength as the reference. 
Statistical analyses performed by Cox proportional hazard model, unadjusted and adjusted for: 1) age and gender; 2) age, gender, education 
level, job position and social help; 3) age, gender, education level, job position, social help, waist-to-hip ratio and height; 4) absolute CV risk 
according to SCORE risk equation; 5) absolute CV risk according to Framingham 2001 risk equation, and 6) absolute CV risk according to PROCAM 
2007 risk equation.
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Supplementary table 6: Association between low grip strength, overall mortality and incident 
cardiovascular events, unadjusted and multivariate-adjusted, including questionable grip 
strength measurements. CoLaus Study, Lausanne, Switzerland, 2003-2012. 
 
Overall mortality Incident cardiovascular events 
 
HR [95% CI]  P value HR [95% CI] P value 
Unadjusted 1.46 0.92-2.32 0.11 1.95 1.30-2.93 <0.01 
Model 1 1.13 0.70-1.80 0.62 1.37 0.90-2.07 0.14 
Model 2 1.00 0.62-1.62 1.00 1.20 0.79-1.83 0.39 
Model 3 0.91 0.55-1.49 0.70 1.11 0.72-1.71 0.65 
Model 4 1.08 0.67-1.73 0.76 1.35 0.90-2.04 0.15 
Model 5 1.37 0.86-2.18 0.18 1.53 1.01-2.30 0.04 
Model 6 1.32 0.82-2.11 0.25 1.65 1.09-2.48 0.02 
 
Results are expressed as Hazard Ratio (HR) and 95% confidence interval (CI) for low grip strength using 
normal grip strength as the reference. Statistical analyses performed by Cox proportional hazard model, 
unadjusted and adjusted for: 1) age and gender; 2) age, gender, education level, job position and social 
help; 3) age, gender, education level, job position, social help, waist-to-hip ratio and height; 4) absolute 
CV risk according to SCORE risk equation; 5) absolute CV risk according to Framingham 2001 risk 
equation, and 6) absolute CV risk according to PROCAM 2007 risk equation. 
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Supplementary Table 7: Association between low grip strength and cardiovascular event 
incidence, unadjusted and multivariate-adjusted, after exclusion of amaurosis fugax and 
transient global amnesia events. CoLaus Study, Lausanne, Switzerland, 2003-2012. 
 
Incident cardiovascular events 
 
HR [95% CI] P value 
Unadjusted 1.72 1.09-2.72 0.02 
Model 1 1.19 0.75-1.89 0.46 
Model 2 1.03 0.65-1.65 0.90 
Model 3 0.93 0.57-1.51 0.77 
Model 4 1.21 0.76-1.91 0.43 
Model 5 1.30 0.82-2.06 0.26 
Model 6 1.43 0.90-2.26 0.13 
 
Results are expressed as Hazard Ratio (HR) and 95% confidence interval (CI) for low grip strength using 
normal grip strength as the reference. Statistical analyses performed by Cox proportional hazard model, 
unadjusted and adjusted for: 1) age and gender; 2) age, gender, education level, job position and social 
help; 3) age, gender, education level, job position, social help, waist-to-hip ratio and height; 4) absolute 
CV risk according to SCORE risk equation; 5) absolute CV risk according to Framingham 2001 risk 
equation, and 6) absolute CV risk according to PROCAM 2007 risk equation. 
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Supplementary figure 1: Distribution of grip strength according to gender. CoLaus Study, 
Lausanne, Switzerland, 2003-2012. 
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Supplementary figure 2: Survival and incidence graphs for overall mortality and cardiovascular 
events. CoLaus Study, Lausanne, Switzerland, 2003-2012. 
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